Lucky 13? Pace of 2006 CDER NME Approvals Bests 2005
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
New molecular entity and novel biologic approvals appear to be rebounding from 2005’s low point, an analysis of CDER approvals in 2006 to date suggests.